Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARIX.L Regulatory News (ARIX)

  • There is currently no data for ARIX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Share Purchase

21 Dec 2020 07:00

Arix Bioscience PLC (ARIX) Director Share Purchase 21-Dec-2020 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


Arix Bioscience plc

Director Share Purchase

 

LONDON, 21 December 2020: Arix Bioscience plc ("Arix", LSE: ARIX), a global venture capital company focused on investing in and building breakthrough biotech companies, today announces that Naseem Amin, Executive Chairman, purchased 183,000 ordinary shares ("Ordinary Shares") in the Company on 18 December 2020 at a price of 206p per share, via a corporate entity in which he has a majority beneficial interest.

 

The below notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail of the transaction in number of Ordinary Shares.

 

 PDMR DEALING NOTIFICATION

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Naseem Amin

2

Reason for the notification

a)

Position / status

Executive Chairman

b)

Initial notification /

Amendment

Initial Notification

3

Details of issuer

a)

Name

Arix Bioscience plc

b)

LEI

213800OVT3AHQCXNIX43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of Arix Bioscience plc

Identification code

GB00BD045071

b)

Nature of the transaction

Purchase of Ordinary Shares by Davum Capital Limited, a corporate entity in which Naseem Amin has a majority beneficial interest

c)

Price(s) and volume(s)

Price(s)

Volume(s)

206.00p

183,000

d)

Aggregated information

Aggregated price

Aggregated volume

N/A (single transaction)

N/A (single transaction)

e)

Date of the transaction

18 December 2020

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

For further information:

 

Robert Lyne Chief Operating Officer and General Counsel +44 (0)207 290 1050

 

 

 - Ends -


ISIN:GB00BD045071
Category Code:DSH
TIDM:ARIX
LEI Code:213800OVT3AHQCXNIX43
Sequence No.:90018
EQS News ID:1156507
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
29th Jul 20215:30 pmEQSTransaction in own shares
28th Jul 20215:30 pmEQSTransaction in own shares
27th Jul 20215:05 pmEQSTransaction in own shares
27th Jul 20217:02 amEQSArtios raises $153m in Series C financing
26th Jul 20215:00 pmEQSTransaction in own shares
23rd Jul 20215:05 pmEQSTransaction in own shares
22nd Jul 20215:07 pmEQSTransaction in own shares
21st Jul 20215:19 pmEQSTransaction in own shares
21st Jul 20217:00 amEQSNotice of Results
20th Jul 20215:14 pmEQSTransaction in own shares
19th Jul 20215:19 pmEQSTransaction in own shares
16th Jul 20215:20 pmEQSTransaction in own shares
15th Jul 20215:19 pmEQSTransaction in own shares
14th Jul 20215:08 pmEQSTransaction in own shares
14th Jul 20219:00 amEQSImara announces pricing of public offering
14th Jul 20217:00 amEQSTransaction in own shares
12th Jul 20215:33 pmEQSTransaction in own shares
8th Jul 20215:15 pmEQSTransaction in own shares
7th Jul 20215:37 pmEQSTransaction in own shares
6th Jul 20215:26 pmEQSTransaction in own shares
6th Jul 20217:01 amEQSTeam changes
5th Jul 20214:59 pmEQSTransaction in own shares
1st Jul 20215:09 pmEQSTransaction in own shares
1st Jul 20217:01 amEQSTotal Voting Rights
30th Jun 20215:00 pmEQSTransaction in own shares
29th Jun 20214:54 pmEQSTransaction in own shares
28th Jun 20215:38 pmEQSTransaction in own shares
25th Jun 20214:57 pmEQSTransaction in own shares
24th Jun 20215:21 pmEQSTransaction in own shares
23rd Jun 20215:06 pmEQSTransaction in own shares
22nd Jun 20215:18 pmEQSTransaction in own shares
21st Jun 20215:06 pmEQSTransaction in own shares
18th Jun 20215:13 pmEQSTransaction in own shares
17th Jun 20215:12 pmEQSTransaction in own shares
16th Jun 20215:25 pmEQSTransaction in own shares
15th Jun 20215:40 pmEQSTransaction in own shares
14th Jun 20215:20 pmEQSTransaction in own shares
14th Jun 20212:55 pmEQSResults of Annual General Meeting
11th Jun 20215:01 pmEQSTransaction in own shares
11th Jun 20211:05 pmEQSClinical portfolio update
10th Jun 20215:26 pmEQSTransaction in own shares
9th Jun 20215:15 pmEQSTransaction in own shares
8th Jun 20215:14 pmEQSTransaction in own shares
7th Jun 20215:08 pmEQSTransaction in own shares
4th Jun 20215:13 pmEQSTransaction in own shares
4th Jun 20213:25 pmEQSHarpoon presents updated interim clinical data for HPN424 at the 2021 ASCO Annual Meeting
3rd Jun 20215:34 pmEQSTransaction in own shares
2nd Jun 20215:12 pmEQSTransaction in own shares
1st Jun 20215:35 pmEQSTransaction in own shares
1st Jun 20217:01 amEQSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.